First, optimal CD32-CR direct cytotoxicity requires the presence of significant expression of ICAM1 and CD32-CR ligand(s) as indicated by CD32-CR profound down-regulation in sensitive BC cells. The gene discussed is FCGR2A; the disease is breast cancer.